Skip to main content

Exact Sciences to Participate in September Investor Conferences

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast.

  • Wells Fargo Healthcare Conference, Boston

    Fireside chat on Wednesday, September 4, 2024 at 3:45 p.m. ET

  • Baird Global Healthcare Conference, New York

    Fireside chat on Wednesday, September 11, 2024 at 10:15 a.m. ET

The webcasts can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X (formerly known as Twitter) @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  206.43
+1.57 (0.77%)
AAPL  259.24
-1.34 (-0.51%)
AMD  201.80
-1.57 (-0.77%)
BAC  52.09
-0.68 (-1.29%)
GOOG  310.08
+6.52 (2.15%)
META  650.47
+5.69 (0.88%)
MSFT  397.17
-1.29 (-0.32%)
NVDA  188.07
+0.17 (0.09%)
ORCL  152.49
-4.05 (-2.59%)
TSLA  409.32
-2.39 (-0.58%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.